Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.73 |
| ▸ | CYP19A1 | P11511 | 9/20 | 0.43 |
| ▸ | NQO2 | P16083 | 2/20 | 0.38 |
| ▸ | TNFRSF1A | P19438 | 2/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.34 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.34 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.34 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.33 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.33 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.33 |
| ▸ | TUBB | P07437 | 1/20 | 0.33 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.33 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.33 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.33 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.33 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.33 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.33 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.33 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.33 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1764331 | 0.91 | CYP3A4 (0.74) | CYP3A4TNFRSF1AEGFRERBB2NFE2L2 | |
| SCHEMBL1764330 | 0.91 | CYP3A4 (0.74) | CYP3A4TNFRSF1AEGFRERBB2NFE2L2 | |
| SCHEMBL2129686 | 0.88 | CYP3A4 (0.69) | CYP3A4TNFRSF1AEGFRERBB2 | |
| SCHEMBL2129689 | 0.88 | CYP3A4 (0.69) | CYP3A4TNFRSF1AEGFRERBB2 | |
| SCHEMBL1542800 | 0.88 | CYP3A4 (0.70) | CYP3A4TNFRSF1AEGFRERBB2NFE2L2 | |
| SCHEMBL1542798 | 0.88 | CYP3A4 (0.70) | CYP3A4TNFRSF1AEGFRERBB2NFE2L2 | |
| SCHEMBL1543595 | 0.88 | CYP3A4 (0.65) | CYP3A4CYP19A1TNFRSF1AEGFRERBB2 | |
| SCHEMBL1543597 | 0.88 | CYP3A4 (0.65) | CYP3A4CYP19A1TNFRSF1AEGFRERBB2 | |
| SCHEMBL12678795 | 0.85 | CYP3A4 (0.66) | CYP3A4TNFRSF1AEGFRERBB2 | |
| SCHEMBL2128074 | 0.85 | CYP3A4 (1.00) | CYP3A4TNFRSF1AEGFRERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2307372-B1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | HOFFMANN LA ROCHE (CH) | 2012-04-25 | — | — | EP | claimed |
| US-20100021423-A1 | Heterocyclic antiviral compounds | ROCHE PALO ALTO LLC | 2010-01-28 | — | — | US | claimed |
| US-8273773-B2 | Heterocyclic antiviral compounds | ROCHE PALO ALTO LLC (US) | 2012-09-25 | — | — | US | disclosed |
| US-20100021423-A1 | Heterocyclic antiviral compounds | ROCHE PALO ALTO LLC | 2010-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100021423-A1 | Heterocyclic antiviral compounds | POLR2A, RRM2B, RRP1B | CYP3A4 528/4885CYP19A1 1594/4885NQO2 168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.